PRIMARY DAPSONE CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN IMMUNOCOMPROMISED PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS

被引：19

作者：

LUCAS, CR ^{[1
]}

SANDLAND, AM ^{[1
]}

MIJCH, A ^{[1
]}

SIMPSON, JM ^{[1
]}

机构：

[1] MONASH UNIV,ALFRED HOSP,SCH MED,DEPT SOCIAL & PREVENT MED,MELBOURNE,VIC 3181,AUSTRALIA

来源：

关键词：

D O I：

10.5694/j.1326-5377.1989.tb128450.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：30 / 33

页数：4

共 15 条

[11]

REHM SJ, 1987, 3RD INT C ACQ IMM SY

[12] CONFIDENCE-INTERVALS FOR REPORTING RESULTS OF CLINICAL-TRIALS [J].

SIMON, R .

STEVENS, CE ;

TAYLOR, PE ;

ZANG, EA ;

MORRISON, JM ;

HARLEY, EJ ;

DECORDOBA, SR ;

BACINO, C ;

TING, RCY ;

BODNER, AJ ;

SARNGADHARAN, MG ;

GALLO, RC ;

RUBINSTEIN, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (16) :2167-2172

[14]

VIEIRA J, 1987, 3RD INT C ACQ IMM SY

[15]

1984, WEEKLY SURVEILLANCE, P3